Non-surgical treatments for androgenetic alopecia: a literature review
DOI:
https://doi.org/10.12775/JEHS.2023.41.01.003Keywords
androgenetic alopecia, 5-α-reductase inhibitors, finasteride, microneedling, platelet-rich plasma, low-energy laser therapy, rosemary oil, siRNAAbstract
Androgenetic alopecia is the most common type of hair loss and affects at least 80% of men and half of women before the age of 70, with the incidence increasing with age. Androgenetic alopecia is an ailment conditioned by genetic and hormonal factors, associated with excessive stimulation of the androgen receptor in the cells of the hair follicle. With the development of medicine, more and more therapeutic methods for androgenetic alopecia appear on the market, including minoxidil, 5-α-reductase inhibitors, microneedling, platelet-rich plasma, low-energy laser therapy, rosemary oil, or siRNA. Thanks to the constantly growing amount of scientific research, progressively more is known about the mechanisms of androgenetic alopecia development and potential strategies to stop it. The article analyzes the literature using electronic databases and textbooks to compile methods that can be an effective alternative for people who do not want to undergo surgery. Some of the methods presented in the article have the potential to not only slow down, but also reverse the progression of the disease. However, each of them still has its limitations.
References
Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021 Dec;20(12):3759-3781. doi: 10.1111/jocd.14537. Epub 2021 Nov 6. PMID: 34741573; PMCID: PMC9298335.
Guarrera M, Cardo P, Arrigo P, Rebora A. Reliability of hamilton-norwood classification. Int J Trichology. 2009 Jul;1(2):120-2. doi: 10.4103/0974-7753.58554. PMID: 20927233; PMCID: PMC2938573.
Duskova, M, et al. Is There Male Androgenetic Alopecia the Sign of Male Equivalent of Polycystic Ovary Syndrome or Metabolic Syndrome?. Endocrine Abstracts, 4 Dec. 2006, www.endocrine-abstracts.org/ea/0011/ea0011p366.
Cannarella, R., Condorelli, R.A., Mongioì, L.M. et al. Does a male polycystic ovarian syndrome equivalent exist?. J Endocrinol Invest 41, 49–57 (2018). https://doi.org/10.1007/s40618-017-0728-5
Rodríguez-Gutiérrez R, Salcido-Montenegro A, González-González JG. Early Clinical Expressions of Insulin Resistance: The Real Enemy to Look For. Diabetes Ther. 2018 Feb;9(1):435-438. doi: 10.1007/s13300-017-0348-2. Epub 2017 Dec 5. PMID: 29209995; PMCID: PMC5801234.
Ramsamy K, Subramaniyan R, Patra AK. An observational Study of the Association between Androgenetic Alopecia and Size of the Prostate. Int J Trichology. 2016 Apr-Jun;8(2):62-6. doi: 10.4103/0974-7753.188034. PMID: 27601858; PMCID: PMC4989389.
Vary JC Jr. Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis. Med Clin North Am. 2015 Nov;99(6):1195-211. doi: 10.1016/j.mcna.2015.07.003. Epub 2015 Sep 4. PMID: 26476248.
Kuklińska N. Łysienie Androgenowe - Jak Dihydrotestosteron WPŁYWA Na Nasze Włosy? Centrum Zdrowego Włosa - Gabinet Trychologiczny, 19 June 2020, centrumzdrowegowlosa.pl/jak-dihydrotestosteron-wplywa-na-nasze-wlosy/.
Yun, SI., Lee, SK., Goh, EA. et al. Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia. Sci Rep 12, 1607 (2022). https://doi.org/10.1038/s41598-022-05544-w
Ho, Chin H., et al. Androgenetic Alopecia. StatPearls Publishing, 2022.
Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004 Feb;150(2):186-94. doi: 10.1111/j.1365-2133.2004.05785.x. PMID: 14996087.
Badri, Talel, et al. Minoxidil. StatPearls Publishing, 2023.
Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019 Aug 9;13:2777-2786. doi: 10.2147/DDDT.S214907. Erratum in: Drug Des Devel Ther. 2020 Feb 10;14:575. PMID: 31496654; PMCID: PMC6691938.
Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. J Am Acad Dermatol. 2017 Jul;77(1):136-141.e5. doi: 10.1016/j.jaad.2017.02.054. Epub 2017 Apr 7. PMID: 28396101.
Berger RS, Fu JL, Smiles KA, Turner CB, Schnell BM, Werchowski KM, Lammers KM. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial. Br J Dermatol. 2003 Aug;149(2):354-62. doi: 10.1046/j.1365-2133.2003.05435.x. PMID: 12932243.
Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002 Sep;47(3):377-85. doi: 10.1067/mjd.2002.124088. PMID: 12196747.
Olsen EA, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, Zhang P, Kohut B. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007 Nov;57(5):767-74. doi: 10.1016/j.jaad.2007.04.012. Epub 2007 Aug 29. PMID: 17761356.
Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, Savin RC, Tharp MD. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004 Apr;50(4):541-53. doi: 10.1016/j.jaad.2003.06.014. PMID: 15034503.
Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011 Dec;65(6):1126-1134.e2. doi: 10.1016/j.jaad.2010.09.724. Epub 2011 Jun 23. PMID: 21700360.
do Nascimento IJB, Harries M, Rocha VB, Thompson JY, Wong CH, Varkaneh HK, Guimarães NS, Rocha Arantes AJ, Marcolino MS. Effect of Oral Minoxidil for Alopecia: Systematic Review. Int J Trichology. 2020 Jul-Aug;12(4):147-155. doi: 10.4103/ijt.ijt_19_20. Epub 2020 Sep 19. PMID: 33376283; PMCID: PMC7759057.
Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol. 2002 Feb;46(2):309-12. doi: 10.1067/mjd.2002.119104. PMID: 11807448.
Polak, K. Zastosowanie doustnego minoksydylu w wybranych chorobach przebiegających z utratą włosów. www.mp.pl, https://www.mp.pl/dermatologia/przeglad-badan/293047,zastosowanie-doustnego-minoksydylu-w-wybranych-chorobach-przebiegajacych-z-utrata-wlosow. Accessed 15 May 2023.
Azzouni F, Godoy A, Li Y, Mohler J. The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases. Adv Urol. 2012;2012:530121. doi: 10.1155/2012/530121. Epub 2011 Dec 25. PMID: 22235201; PMCID: PMC3253436.
Iamsumang W, Leerunyakul K, Suchonwanit P. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date. Drug Des Devel Ther. 2020 Mar 2;14:951-959. doi: 10.2147/DDDT.S240615. PMID: 32184564; PMCID: PMC7060023.
Saengmearnuparp, Thiraphat, et al. The Connection of 5-Alpha Reductase Inhibitors to the Development of Depression. Biomedecine & Pharmacotherapie [Biomedicine & Pharmacotherapy], vol. 143, no. 112100, 2021, p. 112100, doi:10.1016/j.biopha.2021.112100.
Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. J Clin Aesthet Dermatol. 2016 Jul;9(7):56-62. Epub 2016 Jul 1. PMID: 27672412; PMCID: PMC5023004.
Traish AM. Post-finasteride syndrome: a surmountable challenge for clinicians. Fertil Steril. 2020 Jan;113(1):21-50. doi: 10.1016/j.fertnstert.2019.11.030. PMID: 32033719.
Maksym RB, Kajdy A, Rabijewski M. Post-finasteride syndrome - does it really exist? Aging Male. 2019 Dec;22(4):250-259. doi: 10.1080/13685538.2018.1548589. Epub 2019 Jan 16. PMID: 30651009.
Giatti S, Diviccaro S, Panzica G, Melcangi RC. Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin? Endocrine. 2018 Aug;61(2):180-193. doi: 10.1007/s12020-018-1593-5. Epub 2018 Apr 19. PMID: 29675596.
Fertig, Raymond M., et al. Sexual Side Effects of 5-α-Reductase Inhibitors Finasteride and Dutasteride: A Comprehensive Review. Dermatology Online Journal, vol. 23, no. 11, 2017, doi:10.5070/d32311037240.
Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women. J Drugs Dermatol. 2018 Apr 1;17(4):457-463. PMID: 29601622; PMCID: PMC6609098.
Chen, Li, et al. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-Analysis. Aesthetic Plastic Surgery, vol. 44, no. 3, 2020, pp. 962–970, doi:10.1007/s00266-020-01621-5.
Hou A, Cohen B, Haimovic A, Elbuluk N. Microneedling: A Comprehensive Review. Dermatol Surg. 2017 Mar;43(3):321-339. doi: 10.1097/DSS.0000000000000924. PMID: 27755171.
Singh A, Yadav S. Microneedling: Advances and widening horizons. Indian Dermatol Online J. 2016 Jul-Aug;7(4):244-54. doi: 10.4103/2229-5178.185468. PMID: 27559496; PMCID: PMC4976400.
Huang T, Shi J, Sang K, Yu C, Xie Y, Chen H, Jin Z, Yan H, Zhao B. The effect of different modes of microneedling technique on random flap survival in rats. J Plast Reconstr Aesthet Surg. 2021 Oct;74(10):2768-2775. doi: 10.1016/j.bjps.2021.03.046. Epub 2021 Mar 29. PMID: 33933393.
Alster, Tina S., and Paul M. Graham. Microneedling: A Review and Practical Guide. Dermatologic Surgery, vol. 44, no. 3, 2018, pp. 397–404, doi:10.1097/DSS.0000000000001248.
English, Robert S., Jr, et al. “Microneedling and Its Use in Hair Loss Disorders: A Systematic Review.” Dermatology and Therapy, vol. 12, no. 1, 2022, pp. 41–60, doi:10.1007/s13555-021-00653-2.
Stevens J, Khetarpal S. Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol. Int J Womens Dermatol. 2018 Sep 21;5(1):46-51. doi: 10.1016/j.ijwd.2018.08.004. PMID: 30809579; PMCID: PMC6374694.
Alves R, Grimalt R. Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia. Dermatol Surg. 2016 Apr;42(4):491-7. doi: 10.1097/DSS.0000000000000665. PMID: 27035501.
Schindl A, Schindl M, Pernerstorfer-Schön H, Schindl L. Low-intensity laser therapy: a review. J Investig Med. 2000 Sep;48(5):312-26. PMID: 10979236.
Darwin E, Heyes A, Hirt PA, Wikramanayake TC, Jimenez JJ. Low-level laser therapy for the treatment of androgenic alopecia: a review. Lasers Med Sci. 2018 Feb;33(2):425-434. doi: 10.1007/s10103-017-2385-5. Epub 2017 Dec 21. PMID: 29270707.
Panahi Y, Taghizadeh M, Marzony ET, Sahebkar A. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. Skinmed. 2015 Jan-Feb;13(1):15-21. PMID: 25842469.
Zhang MM, Bahal R, Rasmussen TP, Manautou JE, Zhong XB. The growth of siRNA-based therapeutics: Updated clinical studies. Biochem Pharmacol. 2021 Jul;189:114432. doi: 10.1016/j.bcp.2021.114432. Epub 2021 Jan 26. PMID: 33513339; PMCID: PMC8187268.
Agrawal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK. RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev. 2003 Dec;67(4):657-85. doi: 10.1128/MMBR.67.4.657-685.2003. PMID: 14665679; PMCID: PMC309050.
Yun, SI., Lee, SK., Goh, EA. et al. Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia. Sci Rep 12, 1607 (2022). https://doi.org/10.1038/s41598-022-05544-w
Kintor Pharmaceutical KX-826 Phase 2 Results with Poster – Follicle Thought. Folliclethought.com,https://folliclethought.com/kintor-pharmaceutical-kx-826-phase-2-results-with-poster/. Accessed 15 May 2023.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Aleksander Woźniak, Martyna Kozłowska, Patryk Sydor, Marcel Wartacz, Rafał Kreft, Adrian Krzysztof Hunek, Anna Maria Bigdoń, Maciej Ćwiek, Przemysław Gorczyca, Mateusz Góra
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 804
Number of citations: 0